The waiting time for prostate cancer treatment in Italy: analysis from the Pros-IT CNR study
- Autori: Gacci, Mauro; Greco, Isabella; Artibani, Walter; Bassi, Pierfrancesco; Bertoni, Filippo; Bracarda, Sergio; Briganti, Alberto; Carmignani, Giorgio; Carmignani, Luca; Conti, Giario; Corvò, Renzo; De Nunzio, Cosimo; Fusco, Ferdinando; Graziotti, Pierpaolo; Maggi, Stefania; Magrini, Stefano M; Mirone, Vincenzo; Montironi, Rodolfo; Muto, Giovanni; Noale, Marianna; Pecoraro, Stefano; Porreca, Angelo; Ricardi, Umberto; Russi, Elvio; Salonia, Andrea; Simonato, Alchiede; Serni, Sergio; Tubaro, Andrea; Zagonel, Vittorina; Crepaldi, Gaetano
- Anno di pubblicazione: 2020
- Tipologia: Articolo in rivista
- OA Link: http://hdl.handle.net/10447/510695
Abstract
Prostate cancer (PCa) is the second most common neoplasm in male patients. To date, there's no certain indication about the maximum waiting time (WT) acceptable for treatment beginning and the impact on oncological and functional outcomes has not been well established.